MBA
BMY icon

McQueen Ball & Associates’s Bristol-Myers Squibb BMY Stock Holding History

McQueen Ball & Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,361
Closed -$214K – 103
2017
Q3 		$214K Buy
+3,361
New +$196K 0.14% 97
2016
Q3 		– Sell
-3,007
Closed -$221K – 105
2016
Q2 		$221K Sell
3,007
-660
-18% -$46.6K 0.16% 93
2016
Q1 		$234K Buy
3,667
+160
+5% +$10.1K 0.17% 87
2015
Q4 		$241K Buy
+3,507
New +$232K 0.22% 77

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

McQueen Ball & Associates's BMY Position: Q4 2017 in Review

McQueen Ball & Associates sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 3,361 shares — an estimated $214K sold.

McQueen Ball & Associates first reported a position in BMY in Q4 2015 and held it in 4 quarters. The position peaked at $241K in Q4 2015. 1,735 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

  • McQueen Ball & Associates reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
  • McQueen Ball & Associates sold 3,361 Bristol-Myers Squibb shares in Q4 2017, an estimated $214K.
  • McQueen Ball & Associates first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 4 quarters.
  • McQueen Ball & Associates's Bristol-Myers Squibb position peaked at $241K in Q4 2015.
  • 1,735 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on McQueen Ball & Associates's 13F filing for Q4 2017, filed 4 Jan 2018.